# Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammation

**Authors:** Federica Laudisi, Mattia Alberto Serra, Lorenzo Tomassini, Massimo Claudio Fantini, Gustavo Monasterio, Ning He, Eduardo Maria Sommella, Angela Ortenzi, Giuseppe Sigismondo Sica, Francesca Zorzi, Teresa Pacifico, Ombretta Melaiu, Cristiano De Stefanis, Valentina D’Oria, Carmine Stolfi, Ivan Monteleone, Eduardo Javier Villablanca, Giovanni Monteleone

PMC · DOI: 10.1186/s12929-026-01224-3 · Journal of Biomedical Science · 2026-02-17

## TL;DR

This study shows that overexpression of Smad7 in gut epithelial cells causes ileal inflammation and mucus depletion by disrupting purine metabolism, particularly adenosine production.

## Contribution

The study reveals a novel role for epithelial Smad7 in driving ileal inflammation through purine metabolic dysregulation.

## Key findings

- Smad7TgCre+ mice developed spontaneous terminal ileitis with mucus depletion and CD8+ T cell infiltration.
- Smad7 overexpression reduced adenosine levels, and oral adenosine reversed ileal pathology and mucus depletion.
- Elevated Smad7 in CD patients correlated with reduced CD73 expression in inflamed ileum.

## Abstract

Defects of the gut epithelial barrier and counter-regulatory mechanisms are a prerequisite for the onset of intestinal inflammation in patients with inflammatory bowel diseases (IBD). Elevated levels of Smad7, an inhibitor of TGF-β1, in both epithelial and immune cells have been associated with the pathological processes observed in IBD. We aim to determine the relevance of Smad7 expression in the epithelial compartment.

We generated mice overexpressing Smad7 in the gut epithelium (Smad7TgCre+) and monitored pathology development. Inflammatory cell infiltration was assessed using multiplex immunofluorescence and flow cytometry. To investigate the molecular mechanisms underlying ileal damage, we performed spatial transcriptomics on frozen ileal samples and metabolomics on intestinal epithelial cells (IECs) from Smad7TgCre+ and control mice. The impact of adenosine on Mucin-2 expression was evaluated through both in vitro and in vivo approaches. Finally, we evaluated the protein expression of CD73 and Smad7 in ileal tissue from Crohn’s disease (CD) patients.

Smad7TgCre+ mice developed spontaneous terminal ileitis, which was characterized by villus shortening and widening, mucus depletion, increased intestinal permeability, and infiltration of CD8 + T cells. By integrating spatial transcriptomics and metabolomics data, we demonstrated that Smad7TgCre+ mice exhibited altered expression of enzymes involved in purine metabolism, particularly CD73, the key enzyme responsible for adenosine production. Consequently, these mice produced lower levels of adenosine, and oral adenosine administration restored mucus production and alleviated the ileal pathology. Lastly, we observed that in the inflamed ileum of CD patients, elevated Smad7 levels were correlated with decreased CD73 expression.

Our data indicate that Smad7 overexpression in IECs is sufficient to promote ileal mucosal damage, which is linked to the impairment of purine metabolism.

The online version contains supplementary material available at 10.1186/s12929-026-01224-3.

## Linked entities

- **Genes:** SMAD7 (SMAD family member 7) [NCBI Gene 4092], NT5E (5'-nucleotidase ecto) [NCBI Gene 4907], MUC2 (mucin 2, oligomeric mucus/gel-forming) [NCBI Gene 423101]
- **Proteins:** SMAD7 (SMAD family member 7), NT5E (5'-nucleotidase ecto), MUC2 (mucin 2, oligomeric mucus/gel-forming)
- **Chemicals:** adenosine (PubChem CID 60961)
- **Diseases:** Crohn’s disease (MONDO:0005011)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Muc2 (mucin 2) [NCBI Gene 17831] {aka 2010015E03Rik, MCM, wnn}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Cd19 (CD19 antigen) [NCBI Gene 12478], Smad7 (SMAD family member 7) [NCBI Gene 17131] {aka Madh7}, Saa1 (serum amyloid A 1) [NCBI Gene 20208] {aka Saa-1, Saa2}, Reg3b (regenerating islet-derived 3 beta) [NCBI Gene 18489] {aka HIP, PAP1, Pap, REG-III}, Cd3e (CD3 antigen, epsilon polypeptide) [NCBI Gene 12501] {aka CD3, CD3epsilon, T3e}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Cebpb (CCAAT/enhancer binding protein beta) [NCBI Gene 12608] {aka C/EBPbeta, CRP2, IL-6DBP, LAP, LIP, NF-IL6}, Ahr (aryl-hydrocarbon receptor) [NCBI Gene 11622] {aka Ah, Ahh, Ahre, In, bHLHe76}, Lyz1 (lysozyme 1) [NCBI Gene 17110] {aka Lyz, Lyzf3, Lzp-s}, Cda (cytidine deaminase) [NCBI Gene 72269] {aka 2210401N16Rik}, H2-Ab1 (histocompatibility 2, class II antigen A, beta 1) [NCBI Gene 14961] {aka Abeta, H-2Ab, H2-Ab, I-Abeta, IAb, Ia-2}, Cldn4 (claudin 4) [NCBI Gene 12740] {aka Cep-r, Cpetr, Cpetr1}, Slc28a2 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 2) [NCBI Gene 269346] {aka 2010208B10Rik, B430217P18, Cnt2, SPNT}, SMAD7 (SMAD family member 7) [NCBI Gene 4092] {aka CRCS3, MADH7, MADH8}, Adipor2 (adiponectin receptor 2) [NCBI Gene 68465] {aka 1110001I14Rik, ADCR2, D6Ucla1e, Paqr2}, Lgr5 (leucine rich repeat containing G protein coupled receptor 5) [NCBI Gene 14160] {aka FEX, Gpr49}, Adora2b (adenosine A2b receptor) [NCBI Gene 11541] {aka A2BAR, A2BR, A2b, AA2BR, ARA2B}, Lcn2 (lipocalin 2) [NCBI Gene 16819] {aka 24p3, NRL, Sip24}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Apoc3 (apolipoprotein C-III) [NCBI Gene 11814] {aka apo-CIII, apoC-III}, LACC1 (laccase domain containing 1) [NCBI Gene 144811] {aka C13orf31, FAMIN, JUVAR}, Smad3 (SMAD family member 3) [NCBI Gene 17127] {aka Madh3}, Reg3g (regenerating islet-derived 3 gamma) [NCBI Gene 19695] {aka REG-3-gamma, reg III-gamma}, Sp1 (trans-acting transcription factor 1) [NCBI Gene 20683] {aka 1110003E12Rik, Sp1-1}, Itgax (integrin alpha X) [NCBI Gene 16411] {aka Cd11c, Cr4, N418}, Adora2a (adenosine A2a receptor) [NCBI Gene 11540] {aka A2AAR, A2aR, AA2AR, ARA2A}, Ada (adenosine deaminase) [NCBI Gene 11486], Adora3 (adenosine A3 receptor) [NCBI Gene 11542] {aka A3AR, A3R, AA3R, ARA3, Gpcr2}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, Nt5e (5' nucleotidase, ecto) [NCBI Gene 23959] {aka 2210401F01Rik, 5'-NT, CD73, NT, Nt5, eNT}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, NT5E (5'-nucleotidase ecto) [NCBI Gene 4907] {aka CALJA, CD73, E5NT, NT, NT5, NTE}, Dntt (deoxynucleotidyltransferase, terminal) [NCBI Gene 21673] {aka Tdt}, Nudt4 (nudix hydrolase 4) [NCBI Gene 71207] {aka 4933436C10Rik, DIPP-2, DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P}, H2-K1 (histocompatibility 2, K1, K region) [NCBI Gene 14972] {aka H-2K, H-2K(d), H2-D1, H2-K, K-f}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Adora1 (adenosine A1 receptor) [NCBI Gene 11539] {aka A1-AR, A1AR, A1R, AA1R, ARA1, Ri}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Smad4 (SMAD family member 4) [NCBI Gene 17128] {aka D18Wsu70e, DPC4, Madh4}, Slc34a2 (solute carrier family 34 (sodium phosphate), member 2) [NCBI Gene 20531] {aka D5Ertd227e, NaPi-2b, Npt2b}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Plb1 (phospholipase B1) [NCBI Gene 665270] {aka 4632413E21Rik, 4930433E17Rik, 4930539A06Rik}, Lct (lactase) [NCBI Gene 226413] {aka Gm100, LAC, LPH, Lphl}
- **Diseases:** colitides (MESH:D003092), CD (MESH:D003424), colorectal cancer (MESH:D015179), gut damage (MESH:C536735), epithelial injury (MESH:D009375), ileal (MESH:D007077), UC (MESH:D003093), Loeys-Dietz syndrome (MESH:D055947), IBD (MESH:D015212), mucosal damage (MESH:D052016), ileitis (MESH:D007079), edema (MESH:D004487), mucosal dysbiosis (MESH:D064806), fibrosis (MESH:D005355), chronic intestinal inflammation (MESH:D007249), hypoxia (MESH:D000860)
- **Chemicals:** isopentane (MESH:C067038), Alexa Fluor-488 (MESH:C000711379), indomethacin (MESH:D007213), Alexa 568 (MESH:C000607448), dUTP (MESH:C027078), glycerol (MESH:D005990), Alexa Fluor-647 (MESH:C569686), haematoxylin (MESH:D006416), HEPES (MESH:D006531), dextran (MESH:D003911), S (MESH:D013455), alpha,beta-methylene ADP (MESH:C523965), H&amp;E (MESH:D006371), Alexa 488 (-), Propyzamide (MESH:C001059), Periodic Acid (MESH:D010504), neomycin (MESH:D009355), 4',6-diamidino-2-phenylindole (MESH:C007293), TNBS (MESH:D014302), guanosine (MESH:D006151), eosin (MESH:D004801), KCl (MESH:D011189), Tween (MESH:D011136), PBS (MESH:D007854), purine (MESH:C030985), chloroform (MESH:D002725), lipid (MESH:D008055), paraformaldehyde (MESH:C003043), EGTA (MESH:D004533), ampicillin (MESH:D000667), AMP (MESH:D000249), DSS (MESH:D016264), guanine (MESH:D006147), metronidazole (MESH:D008795), polyacrylamide (MESH:C016679), Triton X-100 (MESH:D017830), EDTA (MESH:D004492), nitrogen (MESH:D009584), lactose (MESH:D007785), Nonidet P40 (MESH:C010615), TMX (MESH:D013629), P (MESH:D010758), methanol (MESH:D000432), PAS (MESH:D011478), gold (MESH:D006046), inosine (MESH:D007288), leupeptin (MESH:C032854), Adenosine (MESH:D000241), FITC-dextran (MESH:C015219), Alcian Blue (MESH:D000423), acetic acid (MESH:D019342), SDS (MESH:D012967), ACN (MESH:C084683), Mongersen (MESH:C000588548), oligonucleotides (MESH:D009841), DTT (MESH:D004229), NaF (MESH:D012969), vancomycin (MESH:D014640), luminal (MESH:D010634), H2O. (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Helicobacter (genus) [taxon 209], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** A2A, BRAFV600E
- **Cell lines:** SW480 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0546)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12914907/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12914907/full.md

---
Source: https://tomesphere.com/paper/PMC12914907